2004 Annual Meeting | Parkinson's Disease and Movement Disorders Update
| 01:15 PM - 02:00 PM |
Etiology and Pathogenesis of Parkinson’s Disease
C. W. Olanow, MD |
|
| 02:00 PM - 02:50 PM |
Medical and Surgical Treatment of Parkinson’s Disease
Joseph Jankovic, MD, FAAN |
|
| 02:50 PM - 03:10 PM |
Break
|
|
| 03:10 PM - 04:00 PM |
An Update on Dystonia: Classification, Genetics and Treatment
Stanley Fahn, MD, FAAN |
|
| 04:00 PM - 04:50 PM |
Other Hyperkinetic Movement Disorders (Tremors, Tics and Tourette’s Syndrome, Huntington’s Disease, Myoclonus, Ataxias, and Gait Disorders)
Mark Hallett, MD, FAAN |
|
| 04:50 PM - 05:00 PM |
Questions and Answers
|
| Stanley Fahn, MD, FAAN | Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care. |
| Joseph Jankovic, MD, FAAN | Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Motric Bio. Dr. Jankovic has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Jankovic has received research support from Michael J Fox Foundation for Parkinson Research;. The institution of Dr. Jankovic has received research support from Dystonia Coalition. The institution of Dr. Jankovic has received research support from Parkinson's Foundation. |
| No disclosure on file | |
| Mark Hallett, MD, FAAN | Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities. |
| C. W. Olanow, MD | Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation. |